The Global TB Drug Facility: Innovative global procurement

International Journal of Tuberculosis and Lung Disease

Volumn 8, Issue 1, 2004, Pages 130-138

  Kumaresan, Jacob ^a,b   Smith, I ^a   Arnold, V ^a   Evans, P ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b International Trachoma Initiative   (United States)

Author keywords

DOTS; Drug management; Partnership; Procurement; Tuberculosis; Tuberculosis, drug therapy

Indexed keywords

TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COOPERATION; COST CONTROL; DRUG COST; DRUG PACKAGING; DRUG QUALITY; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALARIA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERFORMANCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PURCHASING; REVIEW; STANDARDIZATION; SWITZERLAND; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

ANTITUBERCULAR AGENTS; COMMUNICABLE DISEASE CONTROL; DEVELOPING COUNTRIES; DRUG UTILIZATION; FEMALE; HUMANS; INTERNATIONAL COOPERATION; MALE; NATIONAL HEALTH PROGRAMS; NEEDS ASSESSMENT; POLICY MAKING; SWITZERLAND; TUBERCULOSIS; WORLD HEALTH;

EID: 1642475497     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. De Cock K M, Soro B, Coulibaly I M, Lucas S B. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992; 268: 1581-1587.
2. World Health Organization. WHO Report 2003. Global Tuberculosis control: Surveillance, Planning, Financing. WHO/CDS/TB/2003.316. Geneva, Switzerland: WHO, 2003.
3. World Health Organization. Report of the ad hoc committee on the tuberculosis epidemic. WHO/TB/98.245. Geneva, Switzerland: WHO, 1998.
4. Raviglione M C, Gupta R, Dye C M, Espinal M A. The burden of drug resistant tuberculosis and mechanisms for its control. Ann NY Acad Sci 2001; 953: 88-97.
5. World Health Organization. Global Partnership to Stop TB. Washington Commitment to Stop TB. WHO/CDS/STB/2001.14a. Geneva, Switzerland: WHO, 2001.
6. World Health Organization. Global TB Drug Facility: A global mechanism to ensure uninterrupted access to quality TB drugs for DOTS implementation. WHO/CDS/STB/2001.10a. Geneva, Switzerland: WHO, 2001.
7. Global Alliance for TB Drug Development. The economics of TB drug development. New York, NY: The Global Alliance for TB Drug Development, 2001.
8. World Health Organization. Frequently asked questions about the 4-drug fixed-dose combination tablet recommended by the World Health Organization for treating tuberculosis. WHO/CDS/STB/2002.18. Geneva, Switzerland: WHO, 2002.
9. Blomberg B, Spinaci S, Fourie B, Laing R. The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis. Bull World Health Organ 2001; 79: 61-68.
10. World Health Organization. Fixed-dose combination tablets for the treatment of tuberculosis. WHO/CDS/TB/99.267. Geneva, Switzerland: WHO, 1999.
11. Gupta R, Cegielski J P, Espinal M A, et al. Increasing transparency in partnerships for health-introducing the Green Light Committee. Trop Med Intern Health 2002; 7: 970-976.